Australian Clinical Labs
ACL.AX
#7734
Rank
HK$3.44 B
Marketcap
HK$18.45
Share price
0.00%
Change (1 day)
35.62%
Change (1 year)

Australian Clinical Labs (ACL.AX) - P/B ratio

P/B ratio as of November 2026 : 4.24

According to Australian Clinical Labs's latest financial reports the company has a price-to-book ratio of 0.869518.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Australian Clinical Labs - P/B ratio (from 2022 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-313.10-15.71%
2024-12-313.686.48%
2023-12-313.4535.35%
2022-12-312.55